The present invention relates to a method of preparing an anthocyanin oligomer using a coenzyme derived from an Aspergillus sp. strain, and more particularly to a method of preparing an anthocyanin oligomer by fermenting an anthocyanin monomer with a coenzyme of Aspergillus niger, which is a kind of Aspergillus sp. strain, and with glucosidase, which is an enzyme contained in the coenzyme.
Anthocyanin functions as a natural pigment and also exhibits various physiological activities, such as an antioxidant function, reduction of a cholesterol level, improvement of vision, vascular protection, prevention of arteriosclerosis and heart disease, an anti-ulcer function, an anticancer function, an anti-inflammation function, diabetes suppression, protection from UV radiation, etc. Furthermore, anthocyanin is actively utilized in medicines and is thus receiving attention as a new material for producing health foods and new medicines.
Anthocyanin is unstable in neutral or alkaline solutions, and gradually becomes decolorized when exposed to light even in an acidic solution, and is thus considered to be a structurally unstable material. In particular, factors affecting the stability of an anthocyanin pigment include the chemical structure of anthocyanin, the concentration of the pigment, the pH of the solution, the temperature, the presence or absence of a coexisting pigment, metal ion, enzyme, oxygen, ascorbic acid, sugar, and the like, and the maintenance of chromaticity, that is, the structural stability thereof may vary depending on variation in these factors. Because of this structural instability, many difficulties are encountered in active utilization as foods and medicines, and studies are under way to improve the stability of anthocyanin.
Anthocyanin contained in most food materials is in a monomer form, which is unstable at neutral and alkaline pH and is also weakly resistant to light and heat. The polymer form is present in small amounts in foods but has higher functionality and stability than the monomer, and the typical antioxidant function thereof is also doubled. Recently, research into anthocyanin oligomers that improve subjective symptoms and contrast sensitivity in cases of myopia and amblyopia has been reported.
Related techniques include Korean Patent No. 10-1182630 (Sep. 7, 2012), Korean Patent Application Publication No. 10-2012-0079040 (Jul. 11, 2012), etc.
Aspergillus sp. mold is a useful microorganism for producing enzymes, organic acids and metabolites having pharmacological activity. It has been usefully employed in agriculture as well as in the food industry, the liquor industry, and the pharmaceutical industry, and has been used for producing traditional fermented foods for a long time, and is therefore recognized as a safe strain. Furthermore, since fungi have many exo-enzymes that are secreted to the outside and have a variety of functions, they may be used to economically produce useful materials by means of natural enzymes. There have been conventional reports for the production of anthocyanin oligomers using Aspergillus sp. mold, but the direct use of the strain is problematic in that contamination may occur in the course of production of anthocyanin oligomers.
In order to confirm whether an anthocyanin oligomer may be prepared using an enzyme that is secreted to the outside, without direct use of an Aspergillus sp. strain, the present inventors have devised methods of producing an anthocyanin oligomer using a coenzyme extracted from a culture media of an Aspergillus niger stain and also using as an enzyme glucosidase obtained by analyzing the coenzyme and Viscozyme L, and have ascertained the efficacy thereof, thus culminating in the present invention.
Accordingly, the present invention is intended to provide a method of economically producing an anthocyanin oligomer by synthesizing an anthocyanin oligomer using a coenzyme of Aspergillus niger and also using as an enzyme glucosidase obtained by analyzing the coenzyme and Viscozyme L.
Therefore, the present invention provides a method of preparing an anthocyanin oligomer, comprising: (1) isolating a water-soluble coenzyme from a culture media of an Aspergillus sp. strain; and (2) fermenting an anthocyanin monomer with the coenzyme isolated in step (1).
Preferably, the Aspergillus sp. strain in step (1) is Aspergillus niger.
Preferably, the strain in step (1) is cultured at a temperature of 15 to 30° C. for 4 to 8 days.
Preferably, the coenzyme in step (1) is isolated as an enzyme by adding the culture media with an organic solvent to give a precipitate and dissolving the precipitate in distilled water.
Preferably, the fermenting in step (2) includes mixing the anthocyanin monomer and distilled water at a mass ratio of 1:8 to 1:15 to prepare an anthocyanin monomer solution, after which mixing the anthocyanin monomer solution and the coenzyme isolated in step (1) at a substrate-to-enzyme mass ratio of 40:1 to 60:1.
Preferably, the fermenting in step (2) is performed at a temperature of 15 to 30° C. for 5 to 10 days.
In addition, the present invention provides a method of preparing an anthocyanin oligomer, comprising fermenting an anthocyanin monomer by adding the anthocyanin monomer with a coenzyme, which is present in a culture media of an Aspergillus sp. strain and contains glucosidase as an active ingredient, and with Viscozyme L.
According to the present invention, in order to overcome contamination problems during the culturing process using Aspergillus niger, a coenzyme of Aspergillus niger is extracted and the fermentation process is performed using the same, whereby an anthocyanin oligomer characterized by reduced concern of contamination and superior radical-scavenging effects, compared to existing anthocyanin monomers, can be produced.
Also, an anthocyanin oligomer, obtained through fermentation using glucosidase as an enzyme contained in the coenzyme, can exhibit excellent fermentation efficiency and radical-scavenging ability, and polymerization of the anthocyanin oligomer can be confirmed even upon the fermentation of the enzyme including glucosidase.
Hereinafter, a detailed description will be given of the present invention.
The present invention pertains to a method of preparing an anthocyanin oligomer, comprising (1) isolating a water-soluble coenzyme from a culture media of an Aspergillus sp. strain and (2) fermenting an anthocyanin monomer with the coenzyme isolated in step (1).
The Aspergillus sp. strain in step (1) is preferably Aspergillus niger.
The strain in step (1) is preferably cultured at a temperature of 15 to 30° C. for 4 to 8 days, and more preferably at 25° C. for 5 days.
The coenzyme in step (1) is preferably isolated as an enzyme by adding the culture media with an organic solvent to give a precipitate and dissolving the precipitate in distilled water.
The fermenting in step (2) is preferably includes mixing the anthocyanin monomer and distilled water at a mass ratio of 1:8 to 1:15 to prepare an anthocyanin monomer solution, after which mixing the anthocyanin monomer solution and the coenzyme isolated in step (1) at a substrate-to-enzyme mass ratio of 40:1 to 60:1. The substrate is an anthocyanin monomer. More preferably, the anthocyanin monomer and distilled water are mixed at a mass ratio of 1:10 to prepare an anthocyanin monomer solution, after which the anthocyanin monomer solution and the coenzyme isolated in step (1) are mixed at a mass ratio of 50:1.
The fermenting in step (2) is preferably at a temperature of 15 to 30° C. for 5 to 10 days, and more preferably at 25° C. for 7 days. The amount of the anthocyanin oligomer that is synthesized is increased up to 7 days, but does not change further even over time under conditions after 8 days.
The coenzyme isolated in step (1) contains glucosidase as an active ingredient.
In addition, the present invention pertains to a method of preparing an anthocyanin oligomer, comprising fermenting an anthocyanin monomer by adding the anthocyanin monomer with a coenzyme, which is present in a culture media of an Aspergillus sp. strain and contains glucosidase as an active ingredient, and with Viscozyme L.
A better understanding of the present invention will be given through the following examples, which are merely set forth to illustrate the present invention but are not to be construed as limiting the scope of the present invention, as will be apparent to those skilled in the art.
As summarized in
After the fermentation, a filtration process was performed using filter paper, whereby materials other than anthocyanin, such as the strain and the like, were filtered and thus the anthocyanin oligomer was isolated and lyophilized, thereby obtaining an anthocyanin oligomer. In order to purify the anthocyanin oligomer, filtration is preferably conducted using a tubular, capillary, coiled spiral, or plane membrane.
An anthocyanin monomer serving as a control was subjected to peak observation through ESI mass spectrometry. As shown in
In order to compare the efficacy of the anthocyanin monomer with that of the anthocyanin oligomer, as shown in
As summarized in
Next, as summarized in
After the fermentation, a filtration process was performed using filter paper, whereby materials other than anthocyanin were filtered and thus the anthocyanin oligomer was isolated and lyophilized, thereby obtaining an anthocyanin oligomer. In order to purify the anthocyanin oligomer, filtration is preferably conducted using a tubular, capillary, coiled spiral, or plane membrane.
An anthocyanin monomer serving as a control was subjected to peak observation through ESI mass spectrometry. The results are shown in
In order to investigate the properties of the isolated coenzyme for synthesizing an anthocyanin oligomer and the culture conditions thereof, SDS-PAGE was performed. The results are shown in
As indicated by the rectangle in
gi|224027
glucoamylase G1
627
65448
ficuum, NRRL 3135, Peptide, 583 aa]
gi|257187
alpha-glucosidase P2 subunit, ANP P2 subunit {EC
181
79656
3.2.1.20} [Aspergillus niger, Peptide, 719 aa]
gi|2344
preproglucoamylase G2 [Aspergillus niger]
531
56695
niger CBS 513.88]
gi|145241490
1,3-beta-glucanosyltransferase gel3 [Aspergillus
161
56721
niger CBS 513.88]
niger CBS 513.88]
niger CBS 513.88]
gi|145233743
alpha-galactosidase B [Aspergillus niger CBS
392
48796
513.88]
gi|74626383
RecName: Full = Probable alpha-galactosidase B;
175
48753
AltName: Full = Melibiase B; Flags: Precursor
niger CBS 513.88)
gi|145232359
endopolygalacturonase C [Aspergillus niger CBS
241
37796
513.88]
gi|145235523
glucan endo-1,3-beta-glucosidase eglC [Aspergillus
129
46778
niger CBS 513.88]
gi|145230419
glycosidase crf1 [Aspergillus niger CBS 513.88]
107
39862
gi|129935
RecName: Full-Endopolygalacturonase II;
89
37489
Short = EPG-II; AltName: Full = Pectinase 2;
AltName: Full = Polygalacturonase II; Short = PG-II;
AltName: Full = Polygalacturonase X2; Flags:
Precursor
gi|145229151
endo-1,3(4)-beta-glucanase [Aspergillus niger CBS
83
46311
513.88]
niger]
As summarized in
Viscozyme L is an enzyme that includes glucosidase and is commercially available.
After the fermentation, a filtration process was performed using filter paper, whereby materials other than anthocyanin were filtered and thus the anthocyanin oligomer was isolated and lyophilized, thereby obtaining an anthocyanin oligomer. In order to purify the anthocyanin oligomer, filtration is preferably conducted using a tubular, capillary, coiled spiral, or plane membrane.
An anthocyanin monomer serving as a control was subjected to peak observation through ESI mass spectrometry. The results are shown in
In order to compare the efficacies of the anthocyanin oligomers obtained using individual enzymes, as shown in
Having described specific portions of the present invention in detail, those skilled in the art will appreciate that these specific embodiments are merely preferred embodiments and that the scope of the present invention is not limited thereby. Accordingly, the actual scope of the present invention will be defined by the appended claims and equivalents thereof.
Number | Date | Country | Kind |
---|---|---|---|
10-2016-0010085 | Jan 2016 | KR | national |
This patent application is a continuation of PCT Application No. PCT/KR2016/008429, filed Aug. 1, 2016, which claims priority to Korean Patent Application No. 10-2016-0010085, filed Jan. 27, 2016, the entire contents of which is incorporated herein for all purposes by this reference.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/KR2016/008429 | Aug 2016 | US |
Child | 16046012 | US |